日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A phase II Japanese trial of 90-minute rituximab infusion for untreated B-cell lymphoma

一项针对未经治疗的B细胞淋巴瘤的90分钟利妥昔单抗输注的II期日本临床试验

Saito, Toko; Nagai, Hirokazu; Izutsu, Koji; Ando, Kiyoshi; Igarashi, Tadahiko; Izumi, Tohru; Ohashi, Yasuo; Kamiyama, Shuhei; Ishizawa, Kenichi; Tobinai, Kensei

A prospective analysis of two studies that used the 5-mm interval slices and 5-mm margin-free method for ipsilateral breast tumor recurrence after breast-conserving surgery without radiotherapy

对两项采用 5 毫米间隔切片和 5 毫米无边缘方法评估保乳手术后同侧乳腺肿瘤复发(未接受放疗)的研究进行前瞻性分析

Ohsumi, Shozo; Nishimura, Reiki; Masuda, Norikazu; Akashi-Tanaka, Sadako; Suemasu, Kimito; Yamauchi, Hideko; Tokunaga, Eriko; Ikeda, Tadashi; Nishi, Tsunehiro; Hayashi, Hiroto; Iino, Yuichi; Takatsuka, Yuichi; Ohashi, Yasuo; Inaji, Hideo

Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular events

他汀类药物治疗中低密度脂蛋白胆固醇水平的最佳目标:与心血管事件单调关系的挑战

Sakuma, Masashi; Iimuro, Satoshi; Shinozaki, Tomohiro; Kimura, Takeshi; Nakagawa, Yoshihisa; Ozaki, Yukio; Iwata, Hiroshi; Miyauchi, Katsumi; Daida, Hiroyuki; Suwa, Satoru; Sakuma, Ichiro; Nishihata, Yosuke; Saito, Yasushi; Ogawa, Hisao; Matsuzaki, Masunori; Ohashi, Yasuo; Taguchi, Isao; Toyoda, Shigeru; Inoue, Teruo; Nagai, Ryozo

A Comparative Study of Serum Phosphate and Related Parameters in Chronic Kidney Disease between the USA and Japan

美国和日本慢性肾脏病患者血清磷酸盐及相关参数的比较研究

Fujii, Naohiko; Hamano, Takayuki; Hsu, Jesse Y; Imai, Enyu; Akizawa, Tadao; Nitta, Kosaku; Watanabe, Tsuyoshi; Iimuro, Satoshi; Ohashi, Yasuo; Matsuo, Seiichi; Makino, Hirofumi; Hishida, Akira; Alper, Arnold B; Horwitz, Edward J; Hsu, Chi-Yuan; Porter, Anna C; Wolf, Myles; Yang, Wei; Nessel, Lisa; Feldman, Harold I

High-Density Lipoprotein Cholesterol and Cardiovascular Events in Patients with Stable Coronary Artery Disease Treated with Statins: An Observation from the REAL-CAD Study

他汀类药物治疗稳定型冠状动脉疾病患者的高密度脂蛋白胆固醇与心血管事件:来自 REAL-CAD 研究的观察

Omote, Kazunori; Yokota, Isao; Nagai, Toshiyuki; Sakuma, Ichiro; Nakagawa, Yoshihisa; Kamiya, Kiwamu; Iwata, Hiroshi; Miyauchi, Katsumi; Ozaki, Yukio; Hibi, Kiyoshi; Hiro, Takafumi; Fukumoto, Yoshihiro; Mori, Hiroyoshi; Hokimoto, Seiji; Ohashi, Yasuo; Ohtsu, Hiroshi; Ogawa, Hisao; Daida, Hiroyuki; Iimuro, Satoshi; Shimokawa, Hiroaki; Saito, Yasushi; Kimura, Takeshi; Matsuzaki, Masunori; Nagai, Ryozo; Anzai, Toshihisa

Efficacy and safety of first-line osimertinib treatment and postprogression patterns of care in patients with epidermal growth factor receptor activating mutation-positive advanced non-small cell lung cancer (Reiwa study): study protocol of a multicentre, real-world observational study

一线奥希替尼治疗表皮生长因子受体激活突变阳性晚期非小细胞肺癌患者的疗效和安全性以及疾病进展后的治疗模式(令和研究):一项多中心、真实世界观察性研究的研究方案

Watanabe, Kageaki; Yoh, Kiyotaka; Hosomi, Yukio; Usui, Kazuhiro; Naka, Go; Kishi, Kazuma; Uemura, Kohei; Ohashi, Yasuo; Kunitoh, Hideo

Final report on plasma ctDNA T790M monitoring during EGFR-TKI treatment in patients with EGFR mutant non-small cell lung cancer (JP-CLEAR trial)

EGFR突变型非小细胞肺癌患者接受EGFR-TKI治疗期间血浆ctDNA T790M监测的最终报告(JP-CLEAR试验)

Naka, Go; Yokoyama, Takuma; Usui, Kazuhiro; Ishida, Hiroo; Kishi, Kazuma; Uemura, Kohei; Ohashi, Yasuo; Kunitoh, Hideo

Effect of a Multifactorial Intervention on Fracture in Patients With Type 2 Diabetes: Subanalysis of the J-DOIT3 Study

多因素干预对2型糖尿病患者骨折的影响:J-DOIT3研究的亚组分析

Sasako, Takayoshi; Ueki, Kohjiro; Miyake, Kana; Okazaki, Yukiko; Takeuchi, Yasuhiro; Ohashi, Yasuo; Noda, Mitsuhiko; Kadowaki, Takashi

Sustained Neutralizing Antibodies 6 Months Following Infection in 376 Japanese COVID-19 Survivors

376名日本新冠肺炎康复者感染后6个月体内持续存在的中和抗体

Goto, Atsushi; Go, Hirofumi; Miyakawa, Kei; Yamaoka, Yutaro; Ohtake, Norihisa; Kubo, Sousuke; Jeremiah, Sundararaj Stanleyraj; Mihara, Takahiro; Senuki, Kotaro; Miyazaki, Tomoyuki; Ikeda, Satoshi; Ogura, Takashi; Kato, Hideaki; Matsuba, Ikuro; Sanno, Naoko; Miyakawa, Masaaki; Ozaki, Haruo; Kikuoka, Masakazu; Ohashi, Yasuo; Ryo, Akihide; Yamanaka, Takeharu

Patient-reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial

局部晚期前列腺癌患者接受新辅助内分泌治疗、体外放射治疗和辅助持续/间歇内分泌治疗后的患者报告结局:一项随机III期试验

Yokomizo, Akira; Koga, Hirofumi; Ito, Kazuto; Takezawa, Yutaka; Komiyama, Motokiyo; Nishimura, Kazuo; Yonese, Junji; Hashine, Katsuyoshi; Masumori, Naoya; Arai, Gaku; Saito, Shiro; Shinohara, Mitsuru; Shimizu, Nobuaki; Yamauchi, Atsushi; Satoh, Takefumi; Tochigi, Tatsuo; Kobayashi, Mikio; Fujimoto, Hiroyuki; Kakimoto, Ken-Ichi; Fukui, Iwao; Tsukamoto, Taiji; Nozaki, Miwako; Karasawa, Katsuyuki; Hasumi, Masaru; Ohtani, Mikinobu; Ishiyama, Hiromichi; Kuwahara, Masaaki; Harada, Masaoki; Ohashi, Yasuo; Kotake, Toshihiko; Kakizoe, Tadao; Suzuki, Kazuhiro; Naito, Seiji; Yamanaka, Hidetoshi